Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

How Should US FDA Navigate Thorny First Amendment Conundrums: Former Chief Counsels Offer Advice

Oct 24 2018

• By Michael Cipriano

Man with mouth covered by masking tape

Related Content

Advertising Enforcement: US FDA Content To Let Competitors 'Duke It Out,' Woodcock Says

Sep 24 2018

Xtampza ER Warnings Can't Be Hidden Behind Table And Chairs, US FDA Tells Collegium

Feb 22 2018

Rx Drug Ads: New US FDA Studies Target Accelerated Approval Information

Mar 12 2018

Consumer-Focused Off-Label Promotion Seems Possible After Amarin Settlement

Mar 14 2016

FDA Outlines Next Steps For Online Repository And Standard Elements For Device Labeling

May 06 2013

Off-Label Promotion Settlement Includes Optional Preclearance Process

Mar 10 2016

Related Companies

Eisai Co., Ltd.

Amarin Corp plc

Additional Topics

United States Advertising, Marketing & Sales Legal Issues FDA Regulation Medical Device BioPharmaceutical

More from Legal & IP

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window